| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |